Medical News

RSS

Nanobiotix, PharmaEngine partner to commercialize NBTXR3 for soft tissue sarcoma

PharmaEngine, Inc. announced today the execution of an exclusive license and collaboration agreement with France-based Nanobiotix S.A. for the development and commercialization of NBTXR3, currently being investigated in a phase I study with soft tissue sarcoma patients.

6 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

TWi Pharmaceuticals, Inc., a specialty pharmaceutical company based in Taiwan, today announced its fully owned subsidiary, TWi Biotechnology, Inc. has completed a multinational phase II dose-ranging study of AC-201, an orally available IL-1 Beta modulator, in 259 patients with type II diabetes uncontrolled on up to three oral medications.

6 Aug 2012

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Foundation Medicine, Inc. and Clovis Oncology, Inc. announced today that they have entered into a diagnostic collaboration.

6 Aug 2012

Medicines with the same active ingredient and size of dose will work the same in the body

In the wake of reports that a number of medicines will increase in price this week, NPS MedicineWise is reminding Australians that while the cost of a medicine may differ from brand to brand, if the active ingredient and size of the dose are the same then the medicine will work the same in their body.

6 Aug 2012

Common ragweed may induce airways irritation through terpenoids

Allergy to pollen of common ragweed is increasingly affecting patients and is second only to grass pollen in terms of incidence in the general population of many European countries.

6 Aug 2012

Medication reconciliation in hospitals: an interview with Dr. Leonard Feldman

Adverse drug effects are harms caused by the use of a medication. There are many different types of ADEs, including medication errors.

6 Aug 2012

Vitamin E total knee replacement performed at Tri-City Medical Center

Dr. James Helgager, an experienced orthopedic surgeon, implanted the first vitamin E Total Knee Replacement in San Diego County on July 31 at Tri-City Medical Center in Oceanside. Helgager is the Medical Director of Joint Replacement for the Orthopaedic & Spine Institute at Tri-City Medical Center. He has been practicing medicine for more than three decades and has performed thousands of total knee replacements.

6 Aug 2012

Scientists identify key factor that drives resistance to cancer drug

Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors - such as those of the breast, prostate, lung and colon - that have metastasized, or spread, throughout the body. A team of scientists led by Fred Hutchinson Cancer Research Center has discovered a key factor that drives this drug resistance - information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer.

6 Aug 2012

Associate director of Clinical Genetics receives Angelo DiGeorge Medal of Honor

Donna McDonald-McGinn, M.S., CGC, associate director of Clinical Genetics and program director of the "22q and You" Center at The Children's Hospital of Philadelphia, received the Angelo DiGeorge Medal of Honor on July 6 at the 8th Biennial International 22q11.2 DS Conference in Lake Buena Vista, Florida. Ms. McDonald-McGinn, who began her career at CHOP in 1985, is the second person to receive this highly esteemed honor.

6 Aug 2012

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

6 Aug 2012

Astellas announces closure of Urogenix research facility

Astellas Pharma Inc. announced that it decided to close Urogenix, Inc., an Astellas subsidiary, which is a research facility focusing on drug discovery in the field of urology.

6 Aug 2012

Study focuses on factors related to obesity in nurses with adverse work schedules

For nurses who work long hours or other "adverse work schedules," the risk of obesity is related to lack of opportunity for exercise and sleep, suggests a study in the August issue of Journal of Occupational and Environmental Medicine, the official publication of the American College of Occupational and Environmental Medicine (ACOEM).

6 Aug 2012

Prior contralateral amputation predicts outcomes after LEB for critical limb ischemia

Researchers from the Vascular Study Group of New England (VSGNE) report that prior contralateral amputation predicts worse outcomes for lower extremity bypasses (LEB's) performed in the intact limb.

6 Aug 2012

Computerized brain fitness program improves memory and language skills in older adults

UCLA researchers found that older adults who regularly used a brain fitness program played on a computer demonstrated significantly improved memory and language skills.

6 Aug 2012

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore Medical Center has launched the nation's first fellowship program in Women's Physical Medicine and Rehabilitation (WPM&R), and established a new clinical program in this specialty.

6 Aug 2012

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

From Luminex 6 Aug 2012

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.

6 Aug 2012

Neutrophils play an unexpected role in mediating insulin resistance

Researchers at the University of California, San Diego School of Medicine say neutrophils, an abundant type of white blood cell typically tasked with attacking bacteria and other foreign invaders, also plays an unexpected role in mediating insulin resistance - the central characteristic of type 2 diabetes, which afflicts an estimated 26 million Americans.

6 Aug 2012

UCSF/SFGH report addresses widespread gaps in health literacy and shows how to bridge them

Is it possible for a health care system to redesign its services to better educate patients to deal with their immediate health issues and also become more savvy consumers of medicine in the long run? The answer is yes, according to a study led by scientists at the University of California, San Francisco (UCSF) and San Francisco General Hospital and Trauma Center (SFGH) that was recently reported by the Institute of Medicine (IOM).

6 Aug 2012

Medical News

Nanobiotix, PharmaEngine partner to commercialize NBTXR3 for soft tissue sarcoma

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

TWi Pharmaceuticals completes AC-201 phase II study on type II diabetes

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Medicines with the same active ingredient and size of dose will work the same in the body

Common ragweed may induce airways irritation through terpenoids

Medication reconciliation in hospitals: an interview with Dr. Leonard Feldman

Vitamin E total knee replacement performed at Tri-City Medical Center

Scientists identify key factor that drives resistance to cancer drug

Associate director of Clinical Genetics receives Angelo DiGeorge Medal of Honor

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Astellas announces closure of Urogenix research facility

Study focuses on factors related to obesity in nurses with adverse work schedules

Prior contralateral amputation predicts outcomes after LEB for critical limb ischemia

Computerized brain fitness program improves memory and language skills in older adults

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Neutrophils play an unexpected role in mediating insulin resistance

UCSF/SFGH report addresses widespread gaps in health literacy and shows how to bridge them

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News